Brisbane, California
United States
8
2021-07-29
8
2022-11-22
These are the the leading inventors for applications assigned to Second Genome, Inc.:
Second Genome, Inc. based in Brisbane, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Proteins for the treatment of epithelial barrier function disorders
#2 | 2020-07-30 ✅ Patent 11,344,584 granted on 2022-05-31as a biotherapeutic
#3 | 2020-07-30 ✅ Patent 11,389,487 granted on 2022-07-19as a biotherapeutic
#4 | 2020-06-11 ✅ Patent 11,174,293 granted on 2021-11-16Proteins for the treatment of epithelial barrier function disorders
#5 | 2020-06-04 ✅ Patent 11,666,627 granted on 2023-06-06Proteins for the treatment of epithelial barrier function disorders
#6 | 2020-05-14 ✅ Patent 11,207,376 granted on 2021-12-28Proteins for the treatment of epithelial barrier function disorders
#7 | 2020-05-07 ✅ Patent 11,473,133 granted on 2022-10-18Methods for validation of microbiome sequence processing and differential abundance analyses via multiple bespoke spike-in mixtures
#8 | 2020-02-27 ✅ Patent 11,273,198 granted on 2022-03-15Proteins for the treatment of epithelial barrier function disorders
Also check out Second Genome, Inc.'s (Brisbane, United States) applicant profile with 4 patent applications submitted.
374195 ⎘